Newsroom

News and safety alerts

868 items

Announcements, product safety communications and regulatory updates.

Safety Alerts

Tenofovir Alafenamide: Risk of Renal Adverse Effects

Overview Tenofovir alafenamide (TAF) is a prodrug of the active metabolite tenofovir, which belongs to the drug group of nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs). In Malaysia…

PENGUMUMAN

Additional Indications Approved (2)

Approved Additional Indication DCA 369 Approved Additional Indication DCA 368 Approved Additional Indication DCA 367 Approved Additional Indication DCA 366 Approved Additional Indication DCA 365…

Document attached

PENGUMUMAN

Kajian Kepuasan Pelanggan NPRA tahun 2022

Tuan / Puan,Bahagian Regulatori Farmasi Negara (NPRA) sedang menjalankan kajian untuk menilai tahap kepuasan pelanggan terhadap perkhidmatan yang diberikan oleh NPRA. Melalui maklumbalas yang…

Announcement

NPRA Customer Satisfaction Survey 2022

Dear Sir / Madam,Bahagian Regulatori Farmasi Negara (NPRA) is conducting a survey to assess the level of customer satisfaction on the services provided by NPRA. Through the feedback received, NPRA…

Safety Alerts

Clindamycin: Risk of Acute Renal Failure

The NPRA has updated information about this safety issue. See the NPRA Safety Alerts published on 7 August 2023. Overview Clindamycin is a lincosamide antibiotic indicated for the treatment of…

Announcement QUEST

Issues on Accessing QUEST3+ with Avast Antivirus

Dear Applicant, Recently we have received numerous complaints regarding problem on accessing QUEST3+ System. User who use Avast as antivirus have problem accessing QUEST system as Avast blocked…

Document attached

Safety Alerts

Decitabine: Risk of Differentiation Syndrome

Overview Decitabine is a hypomethylating agent1 that selectively inhibits DNA methylation and is indicated for the treatment of myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML) in…

Document attached

Safety Alerts

Anastrozole: Risk of Depression

Overview Anastrozole is a potent and highly selective non-steroidal aromatase inhibitor, which is indicated for the treatment of breast cancer in postmenopausal women.1 Depression is a mental…